Abstract Details
Prashanth Rajarajan, MD, PhD
(Brigham and Women's Hospital)
PRESENTER |
Dr. Rajarajan has nothing to disclose. |
Marinos G. Sotiropoulos, MD (Massachusetts General Hospital) | Dr. Sotiropoulos has stock in Moderna. Dr. Sotiropoulos has stock in Ikena Oncology. Dr. Sotiropoulos has stock in Cassava Sciences. Dr. Sotiropoulos has stock in Biogen. Dr. Sotiropoulos has stock in Tiziana Life Sciences. Dr. Sotiropoulos has received publishing royalties from a publication relating to health care. |
Galina Gheihman, MD (Brigham & Women's Hospital) | Dr. Gheihman has nothing to disclose. |
Sarah Conway, MD (BWH) | Dr. Conway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |